Edition:
United Kingdom

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

14.52USD
16 Aug 2019
Change (% chg)

$-0.30 (-2.02%)
Prev Close
$14.82
Open
$14.87
Day's High
$15.07
Day's Low
$14.50
Volume
65,425
Avg. Vol
92,901
52-wk High
$26.49
52-wk Low
$5.62

About

Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocyt... (more)

Overall

Beta: --
Market Cap(Mil.): $447.49
Shares Outstanding(Mil.): 28.23
Dividend: --
Yield (%): --

Financials

  DOVA.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -2.66 -- --
ROI: -73.52 7.52 12.69
ROE: -79.51 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates